Jesus Avila | Tauopathies | Best Researcher Award

Published on by Cognitive Scientist Awards

Prof. Jesus Avila | Tauopathies | Best Researcher Award

Dr. Jesus Avila is a distinguished cognitive scientist and Professor ad honorem at the Centro de Biologia Molecular Severo Ochoa (CBM-CSIC), Spain. He obtained his degree in Chemistry and PhD in Molecular Biology from Universidad Complutense Madrid, focusing on RNA polymerase in B. subtilis. His postdoctoral research at NIH, USA, centered on the SV40 virus. Throughout his prolific career, Dr. Avila has made groundbreaking contributions to understanding the neuronal cytoskeleton, particularly tau protein, its role in Alzheimer’s disease, and tauopathies. With over 694 published journal articles, 33 books, 4 patents, and collaborations across the USA, France, UK, Germany, and Spain, his work is internationally recognized. He serves on editorial boards of prestigious journals including EMBO J, FEBS Letters, Neuroscience, and Journal of Alzheimer’s Disease (Deputy Editor). Dr. Avila is a member of EMBO, Academia Europaea, AAAS, and Royal Academies of Sciences and Medicine of Spain.

Professional Profile

Education

Dr. Jesus Avila pursued his higher education at Universidad Complutense Madrid (UCM), earning a degree in Chemistry. He further specialized by completing a PhD in Molecular Biology at UCM, where his research focused on the B. subtilis RNA polymerase system. This solid foundation in molecular biology provided him with the expertise to investigate complex neurobiological mechanisms. He then advanced his academic career with postdoctoral training at the National Institutes of Health (NIH) in Bethesda, Maryland, USA, where he studied the SV40 virus—a crucial step that introduced him to advanced molecular virology and neurobiology techniques. This diverse academic background enabled him to establish a globally recognized research portfolio in neurodegeneration, particularly tau protein’s role in neuronal function and dysfunction.

Experience

Dr. Avila has an illustrious career spanning several decades at the Centro de Biologia Molecular Severo Ochoa (CBM-CSIC), where he has led pioneering research into the neuronal cytoskeleton, tau protein dysfunction, and neurodegenerative diseases. His early research at NIH on SV40 virus provided him with robust molecular expertise, which he translated into comprehensive studies on tauopathies and Alzheimer’s disease upon returning to Spain. Dr. Avila has successfully led over 30 major research projects, consulted on 8 industry collaborations, and published 694 peer-reviewed articles. His work includes the authorship of 33 books and the filing of 4 patents. Through sustained collaborations with global leaders in neuroscience from the USA, France, UK, Germany, and Spain, he has significantly advanced the understanding of aging and cognitive decline. His academic leadership and editorial roles underscore his vast experience in guiding both research and scientific discourse.

Research Interests

Dr. Avila’s research primarily investigates the neuronal cytoskeleton, with a central focus on tau protein and its role in neurodegeneration. Beginning with tau’s structural function in neurons, his work has expanded to explore how tau dysfunction contributes to Alzheimer’s disease and other tauopathies. Utilizing molecular and cellular approaches, including advanced mouse models, he has dissected the pathological mechanisms linking tau pathology to cognitive decline. Recognizing aging as the principal risk factor for Alzheimer’s disease, his current investigations target neuronal rejuvenation strategies to mitigate age-associated neurodegeneration. His integrative approach combines molecular biology, neurogenetics, and translational models, contributing significantly to the understanding of disease progression and potential therapeutic interventions. Through over 694 publications, 33 books, multiple patents, and international collaborations, Dr. Avila has substantially advanced the field of cognitive neuroscience, particularly in understanding and combating tau-mediated cognitive disorders.

Awards

Dr. Avila’s exemplary contributions have earned him numerous prestigious honors. He is an elected member of EMBO (European Molecular Biology Organization), Academia Europaea, AAAS (American Association for the Advancement of Science), and both the Royal Academies of Sciences and Medicine of Spain—testament to his global recognition and scientific excellence. His editorial appointments with highly respected journals such as EMBO J, FEBS Letters, Neuroscience, and his role as Deputy Editor of the Journal of Alzheimer’s Disease further validate his authority in cognitive and neurodegenerative research. His citation index surpasses 100 on Scopus, reflecting the significant influence of his work. His extensive collaborations with leading international research teams highlight his status as a respected leader in the global scientific community. The combination of his research excellence, mentorship, and leadership has positioned him as one of the foremost experts in cognitive science and neurobiology.

Conclusion

Dr. Jesus Avila’s distinguished career combines pioneering research on tau protein and Alzheimer’s disease, extensive international collaborations, over 694 publications, leadership roles in major journals, multiple prestigious memberships, and an unwavering focus on neuronal rejuvenation strategies, positioning him as a world-leading cognitive scientist whose work continues to advance global understanding of neurodegeneration.

 Publications

  • Protein tau phosphorylation in the proline rich region and its implication in the progression of Alzheimer’s disease

    Experimental Neurology
    2025 | Journal article
    DOI: 10.1016/j.expneurol.2024.115049

    EID:

    2-s2.0-85208758184

    Part ofISSN: 10902430 00144886
    CONTRIBUTORS: Merino-Serrais, P.; Soria, J.M.; Arrabal, C.A.; Ortigado-López, A.; Esparza, M.Á.G.; Muñoz, A.; Hernández, F.; Ávila, J.; DeFelipe, J.; León-Espinosa, G.

  • Retrotransposon Protein L1 ORF1p Expression in Aging Central Nervous System

    International Journal of Molecular Sciences
    2025-05-04 | Journal article
    DOI: 10.3390/ijms26094368
    CONTRIBUTORS: Laura Vallés-Saiz; Aaron Abdelkader-Guillén; Jesús Ávila; Félix Hernández

  • Shapeshifter W-Tau Peptide Inhibits Tau Aggregation and Disintegrates Paired Helical Filaments

    Biochemistry
    2025-04-15 | Journal article
    DOI: 10.1021/acs.biochem.4c00809
    CONTRIBUTORS: Indalo Domene-Serrano; Raquel Cuadros; Vega García-Escudero; Francisco Vallejo-Bedia; Ismael Santa-María; Laura Vallés-Saiz; Félix Hernandez; Jesús Avila

  • Peptide Family Promotes Brain Cell Rejuvenation and Improved Cognition through Peripheral Delivery

    ACS Omega
    2025-04-08 | Journal article
    DOI: 10.1021/acsomega.4c10849
    CONTRIBUTORS: Alejandro Anton-Fernandez; Indalo Domene-Serrano; Raquel Cuadros; Rocio Peinado-Cahuchola; Margarita Sanchez-Pece; Felix Hernandez; Jesus Avila

  • Partial reprogramming by cyclical overexpression of Yamanaka factors improves pathological phenotypes of tauopathy mouse model of human Alzheimer\’s disease

    Progress In Neurobiology
    2025-04-01 | Journal article | Author
    DOI: 10.1016/j.pneurobio.2025.102743

    SOURCE-WORK-ID:

    CSIC-GB950859

    EID:

    2-s2.0-85219079150

    Part ofISSN: 0301-0082
    CONTRIBUTORS: Alejandro Anton-Fernandez; Ruiz de Alegría, Álvaro; Mariscal-Casero, Ana; Roldán-Lázaro, Marta; Peinado-Cauchola, Rocío; Jesus Avila; Felix Hernandez

  • Hippocampal rejuvenation by a single intracerebral injection of one‐carbon metabolites in C57BL6 old wild‐type mice

    Aging Cell
    2025-01 | Journal article
    DOI: 10.1111/acel.14365
    CONTRIBUTORS: Alejandro Antón‐Fernández; Rocío Peinado Cauchola; Félix Hernández; Jesús Ávila

  • Intron retention as a productive mechanism in human MAPT: RNA species generated by retention of intron 3

    eBioMedicine
    2024 | Journal article
    DOI: 10.1016/j.ebiom.2023.104953

    EID:

    2-s2.0-85181837483

    Part ofISSN: 23523964
    CONTRIBUTORS: Ruiz-Gabarre, D.; Vallés-Saiz, L.; Carnero-Espejo, A.; Ferrer, I.; Hernández, F.; Garcia-Escudero, R.; Ávila, J.; García-Escudero, V.

  • Involvement of the cellular prion protein in seeding and spreading of sarkosyl-derived fractions of Alzheimer´s disease in Prnp mutant mice and in the P301S transgenic tauopathy mice model

    bioRxiv
    2024 | Other
    DOI: 10.1101/2024.01.20.576414

    EID:

    2-s2.0-85184321414

    Part of ISSN: 26928205
    CONTRIBUTORS: Sala-Jarque, J.; Gil, V.; Andrés-Benito, P.; Lidón, L.; Yanac-Huertas, R.E.; López-León, C.F.; Hernández, F.; Ávila, J.; Lanciego, J.L.; Soriano, J. et al.

Xavier Altafaj | Cognitive Development | Best Researcher Award

Published on by Cognitive Scientist Awards

Assist. Prof. Dr. Xavier Altafaj | Cognitive Development | Best Researcher Award

University of Barcelona, Spain

Xavier Altafaj, PhD (b. Nov 16, 1974, Barcelona , is a neuroscientist and biomedical researcher with deep expertise in glutamatergic neurotransmission . A committed leader in translational research, he currently serves as Principal Investigator of the “Glutamatergic Receptors in Health and Disease” team and Lecturer under the Serra Húnter program at the University of Barcelona . With over two decades of international research spanning France , Belgium , and Spain, Dr. Altafaj has contributed to understanding synaptic function and pathologies in neurodevelopmental and neurodegenerative disorders . He is an active voice in European neuroscience, having collaborated in multiple EU networks and initiatives. His impactful work includes advancing treatments for rare pediatric diseases and conditions like GRIN-related encephalopathies and autism spectrum disorders . Through his scientific leadership and public engagement, he bridges basic research with clinical applications and patient advocacy, reflecting a career marked by innovation, mentorship, and societal relevance .

Profile

Scopus

Scholar

🎓Education 

Dr. Altafaj holds a PhD in Biological Sciences from the University of Barcelona (2002) , where he previously earned his B.Sc. in Biological Sciences (1997) alongside another B.Sc. from Université Libre de Bruxelles . His academic training reflects a strong international dimension, including early specialization in developmental genetics during an Erasmus fellowship in Belgium (1996–97) . His doctoral research at the Department of Molecular Genetics (IRO, Barcelona) involved collaborations with prominent institutions including the Cajal Institute in Madrid and ESPCI in Paris, combining molecular biology, pharmacology, and physiology . Supported by multiple European fellowships , his education laid the groundwork for his lifelong interest in synaptic signaling and ion channel pathophysiology. Dr. Altafaj’s cross-border scientific foundation shaped his capacity to lead innovative research that addresses complex neurobiological questions, from genetic mechanisms to therapeutic approaches for brain disorders , setting the stage for his later roles in translational neuroscience research and teaching .

🧪Professional Experience 

Dr. Altafaj is currently Principal Investigator (since 2011) and Serra Húnter Lecturer (since 2020) at the University of Barcelona’s Faculty of Medicine . From 2011–2020, he led the “Glutamatergic Receptors in Health and Disease” group at IDIBELL as a “Miguel Servet” Researcher . Prior to that, he was Principal Investigator (2008–2010) and Postdoc (2007) at CRG’s Gene Therapy team in Barcelona . His early postdoctoral research (2002–2006) took place in France at Inserm U-607/CEA-Grenoble, investigating calcium channel pathologies . As a PhD student (1997–2002), he trained in molecular genetics in Barcelona with various national and international collaborations. His research has spanned gene therapy, neurodevelopment, and synaptic disorders. Across academic and clinical research centers, Dr. Altafaj has consistently focused on molecular neurobiology and translational science. He’s an active member of European networks and regularly mentors graduate students, making him a pillar in biomedical research and education across Europe .

🏅 Awards & Honors 

Dr. Altafaj has earned prestigious competitive funding and honors across Europe, including multiple tenured “Miguel Servet” investigator positions (2008–2017) , and awards from Down Syndrome foundations for innovative gene therapy work . His projects have attracted major grants from institutions like the Instituto de Salud Carlos III, La Marató TV3, and European ERA-NET NEURON, totaling over €1.5 million in funding . He received early recognition with the Alfred Jost Award (2004, Serono)  and held numerous postdoctoral fellowships (Beatriu de Pinós, AFM, EU CORDIS) . Recent accolades include charity-funded studies for GRIN disorder stratification (GRI-Italia, Grinpatías), and collaborative grants on autism and rare encephalopathies . His leadership in research networks (MINECO, AGAUR) and role as PI in over 20 funded projects showcase his impact in translational neuroscience. These distinctions highlight his success in bridging clinical needs with basic research and improving therapeutic strategies for neurogenetic disorders .

🔬 Research Focus 

Dr. Altafaj’s research explores glutamatergic receptors (particularly NMDA) in health and disease, with an emphasis on synaptopathies, neurodevelopmental disorders, and rare encephalopathies such as GRIN-related syndromes . His lab investigates how mutations in genes like GRIN2B and CNTNAP2 disrupt synaptic signaling and contribute to conditions like autism, epilepsy, and intellectual disability . Using patient-derived models, proteomics, and pharmacological tools, his group develops personalized medicine strategies and functional stratification of variants . Ongoing work includes translational studies on l-serine and spermidine treatments, contributing to experimental therapies for pediatric patients . He also delves into the interaction between glutamate receptors and neuroinflammatory pathways, relevant in diseases like Alzheimer’s . His multidisciplinary approach merges genetics, molecular biology, and neuropharmacology, often in collaboration with clinicians and European consortia . Dr. Altafaj aims to bridge molecular mechanisms with clinical interventions, advancing therapeutic innovation and patient-centered research in neurology and psychiatry .

✅ Conclusion: 

Dr. Xavier Altafaj is a highly suitable candidate for a Best Researcher Award, especially in fields like translational neuroscience, molecular neurogenetics, or rare disease research. His long-term leadership, groundbreaking work on glutamatergic signaling, and consistent research funding validate his excellence in academia and applied health sciences. While there is room to amplify his global visibility and innovation footprint, his current record already reflects the high standards expected of award recipients.

Publication

  • Title: Neurodevelopmental delay, motor abnormalities, and cognitive deficits in transgenic mice overexpressing Dyrk1A (minibrain), a murine model of Down’s syndrome
    Authors: X. Altafaj, M. Dierssen, C. Baamonde, E. Martí, J. Visa, J. Guimerà, M. Oset, et al.
    Year: 2001
    Citations: 503

  • Title: Dyrk1A expression pattern supports specific roles of this kinase in the adult central nervous system
    Authors: E. Martí, X. Altafaj, M. Dierssen, S. de la Luna, V. Fotaki, M. Alvarez, et al.
    Year: 2003
    Citations: 174

  • Title: Interaction between the dihydropyridine receptor Ca2+ channel β-subunit and ryanodine receptor type 1 strengthens excitation-contraction coupling
    Authors: W. Cheng, X. Altafaj, M. Ronjat, R. Coronado
    Year: 2005
    Citations: 119

  • Title: DYRK1A autophosphorylation on serine residue 520 modulates its kinase activity via 14-3-3 binding
    Authors: M. Alvarez, X. Altafaj, S. Aranda, S. de la Luna
    Year: 2007
    Citations: 107

  • Title: Transduction of the scorpion toxin maurocalcine into cells: evidence that the toxin crosses the plasma membrane
    Authors: E. Estève, K. Mabrouk, A. Dupuis, S. Smida-Rezgui, X. Altafaj, D. Grunwald, et al.
    Year: 2005
    Citations: 103

  • Title: Motor phenotypic alterations in TgDyrk1a transgenic mice implicate DYRK1A in Down syndrome motor dysfunction
    Authors: M. M. de Lagrán, X. Altafaj, X. Gallego, E. Martí, X. Estivill, I. Sahún, C. Fillat, et al.
    Year: 2004
    Citations: 102

  • Title: Cloning and characterization of DYRK1B, a novel member of the DYRK family of protein kinases
    Authors: S. Leder, Y. Weber, X. Altafaj, X. Estivill, H. G. Joost, W. Becker
    Year: 1999
    Citations: 97

  • Title: Normalization of Dyrk1A expression by AAV2/1-shDyrk1A attenuates hippocampal-dependent defects in the Ts65Dn mouse model of Down syndrome
    Authors: X. Altafaj, E. D. Martín, J. Ortiz-Abalia, A. Valderrama, C. Lao-Peregrín, et al.
    Year: 2013
    Citations: 96

  • Title: Targeting Dyrk1A with AAVshRNA attenuates motor alterations in TgDyrk1A, a mouse model of Down syndrome
    Authors: J. Ortiz-Abalia, I. Sahún, X. Altafaj, N. Andreu, X. Estivill, M. Dierssen, C. Fillat
    Year: 2008
    Citations: 91

  • Title: Glutamate receptor mutations in psychiatric and neurodevelopmental disorders
    Authors: D. Soto, X. Altafaj, C. Sindreu, À. Bayés
    Year: 2014
    Citations: 89

Anish Kumar | Mathematics | Best Scholar Award

Published on by Cognitive Scientist Awards

Dr. Anish Kumar | Mathematics | Best Scholar Award

Dr. Anish Kumar is a dedicated mathematician specializing in applicable analysis, complex analysis, geometric function theory, and special functions. He earned his Ph.D. in Mathematics from the National Institute of Technology (NIT) Jamshedpur, where his research explored geometric properties and representations of Fox-Wright-related special functions. With experience across reputed institutions such as IIT Bhilai, Patna Women’s College, and the Bulgarian Academy of Sciences, he has actively contributed to academic teaching and post-doctoral research. His scholarly work includes impactful publications in internationally recognized journals and participation in several mathematical conferences and workshops. Dr. Kumar also serves as a reviewer for reputed mathematical journals and possesses strong skills in Python, Mathematica, Maxima, R, and LaTeX. His academic journey reflects a consistent focus on deep mathematical theory and its applications, underscoring a promising research career in mathematical sciences.

Professional Profile

Education

Dr. Anish Kumar received his Ph.D. in Mathematics from the National Institute of Technology Jamshedpur (2019–2023), completing a thesis on the geometric properties and representations of special functions related to Fox-Wright functions under Dr. Sourav Das. He earned his M.Sc. in Mathematics from the Central University of South Bihar, Gaya (2016–2018) with a CGPA of 7.21, following a B.Sc. in Mathematics from the College of Commerce, Arts and Science, Patna (2013–2016) with 70.25%. His earlier education includes an Intermediate qualification from Gaya College (71%) and Matriculation from JHS Juri Bankey Bazar (83%). His academic path showcases a steady progression through mathematical theory and advanced special functions, grounded in rigorous foundational study and a keen interest in applied mathematical research.

Experience

Dr. Kumar has accumulated valuable academic and research experience across several esteemed institutions. He worked as a Ph.D. tutor at NIT Jamshedpur, teaching Engineering Mathematics. In 2019, he served as Guest Faculty at Aurangabad Engineering College, followed by similar roles at Bakhtiyarpur Engineering College in 2023. In 2024, he was appointed Assistant Professor at Patna Women’s College and served as a Research Associate at IIT Bhilai. Most recently, he held a Post-Doctoral position at the Bulgarian Academy of Sciences, IICT Sofia, Bulgaria. These roles have provided him with wide-ranging exposure to both undergraduate instruction and collaborative international research. His experience underscores a balanced profile in teaching and academic research with a clear emphasis on mathematical analysis.

Awards and Honors

Dr. Anish Kumar has received several prestigious academic recognitions. He qualified the Joint CSIR-UGC NET for Junior Research Fellowship (JRF) and Lectureship in June 2020 with an impressive AIR of 130. In March 2019, he cleared the GATE exam in Mathematics. Earlier, he passed the Central Universities Common Entrance Test (CUCET) in 2016 and qualified the JEE-Mains in 2013. These qualifications reflect his strong academic aptitude and dedication to competitive scholarship. His scholarly excellence is also evident from his invited participations and presentations at national and international conferences, including those organized by IIT Madras, University of Kerala, and NIT Silchar, further establishing his position in the mathematics research community.

Research Focus

Dr. Kumar’s research is deeply rooted in applicable analysis, geometric function theory, complex analysis, and special functions. His doctoral thesis emphasized geometric properties and representations of special functions related to Fox-Wright functions. His published and under-review works investigate geometric behaviors, monotonicity, inequalities, and integral transforms of functions such as Gauss hypergeometric, Bessel, Le-Roy type, and Mittag-Leffler functions. Collaborating with leading mathematicians, he explores analytical properties of functions critical to mathematical physics and engineering applications. His research is both theoretical and applicable, offering insights into function behavior and contributing to mathematical modeling in applied sciences. He continues to expand his exploration of special functions and their role in modern mathematical analysis.

Conclusion

Professor Georgios Papazisis is highly deserving of the Best Researcher Award. His exceptional contributions to clinical pharmacology, ethical leadership, and global clinical trials reflect sustained excellence and international impact. His blend of academic productivity, regulatory leadership, and commitment to pharmacovigilance makes him a model candidate. By integrating digital innovation and expanding translational outreach, his already stellar profile could become even more transformative in the future.

 Publication

1. Title: Geometric Nature of the Turánian of Modified Bessel Function of the First Kind

Authors: Samanway Sarkar, Dimiter Prodanov, Anish Kumar, Sourav Das
Journal: Axioms
Publication Date: 2024-12-15
DOI: 10.3390/axioms13120874

2. Title: Monotonicity properties and functional inequalities for the Barnes Mittag-Leffler function

Authors: Khaled Mehrez, Sourav Das, Anish Kumar
Journal: Miskolc Mathematical Notes
Year: 2023
DOI: 10.18514/mmn.2023.3997

 3. Title: Integral transforms and probability distributions for a certain class of Fox–Wright type functions and its applications

Authors: Anish Kumar, Sourav Das
Journal: Mathematics and Computers in Simulation
Publication Date: 2023-01
DOI: 10.1016/j.matcom.2022.07.011

4. Title: Certain Geometric Properties of the Fox–Wright Functions

Authors: Anish Kumar, Saiful R. Mondal, Sourav Das
Journal: Axioms
Publication Date: 2022-11-09
DOI: 10.3390/axioms11110629

 5. Title: Geometric Properties of a Certain Class of Mittag–Leffler-Type Functions

Authors: Anish Kumar
Journal: Fractal and Fractional
Publication Date: 2022-01-22
DOI: 10.3390/fractalfract6020054

 6. Title: Geometric Properties of the Products of Modified Bessel Functions of the First Kind

Author: Anish Kumar
Journal: Bulletin of the Malaysian Mathematical Sciences Society
Publication Date: 2021-09
DOI: 10.1007/s40840-021-01082-2

Prof. Dr. Georgios Papazisis | Neuroscience | Best Researcher Award

Published on by Cognitive Scientist Awards

Prof. Dr. Georgios Papazisis | Neuroscience | Best Researcher Award

Professor Georgios Papazisis, MD, PhD, is a Full Professor of Basic and Clinical Pharmacology at the Aristotle University of Thessaloniki, Greece. A certified psychiatrist and clinical pharmacologist, he currently serves as Medical Director of the Clinical Research Unit at Papageorgiou Hospital. He also chairs the postgraduate program in Vaccines and Infectious Diseases and leads the Bioethics Committee at the School of Medicine. He is actively involved in national and European pharmacological and bioethics organizations, including the UEMS and CIOMS. Dr. Papazisis plays a central role in coordinating and supervising early-phase clinical trials and pharmacovigilance activities in Greece. He has published over 110 papers, contributed to international book chapters, and has earned over 3500 citations. A seasoned clinical researcher and educator, his international collaborations and numerous awards underline his commitment to advancing pharmacology, psychiatry, and public health through ethical and evidence-based medical research.

Professional Profile

Education

Dr. Georgios Papazisis obtained his MD from the School of Medicine, Aristotle University of Thessaloniki (1992–1998), followed by a PhD in Pharmacology/Physiology from the same institution (2000–2005). He completed his specialization in Psychiatry at the Psychiatric Hospital of Thessaloniki (2003–2008), and later obtained board certification in the medical sub-specialty of Clinical Pharmacology (2021). He has also received international training in Good Clinical Practice (GCP) from the NIDA Clinical Trials Network, USA (February 2025) and is an Advanced Life Support (ALS) certified provider by the European Resuscitation Council (March 2025). His education emphasizes a strong foundation in both basic science and clinical application, integrating disciplines such as pharmacology, psychiatry, and clinical trial management. This diverse academic background has allowed him to build a career bridging laboratory research, clinical practice, and regulatory science in both national and international settings.

Experience

Professor Papazisis has extensive experience spanning over two decades in psychiatry, pharmacology, and clinical research. Since 2008, he has maintained a private psychiatry practice while actively contributing to academic and institutional research. He became Medical Director of the Clinical Research Unit at Papageorgiou Hospital in 2021 and was appointed Professor of Basic and Clinical Pharmacology in 2023. He has coordinated multiple phase I to IV clinical trials, led vaccine safety evaluations, and participated in EU-funded research including Horizon2020 and the c4c project. His clinical research focuses on drug and vaccine safety, pharmacovigilance, and neuropsychopharmacology. In parallel, he serves as Chair of the Bioethics Committee and leads a postgraduate program on vaccines and infectious diseases. He also acts as Greece’s pharmacovigilance expert for several international studies and is affiliated with global networks such as Vaccelerate, CIOMS, and the World Psychiatric Association’s Evidence-Based Psychiatry section.

Awards and Honors

Dr. Georgios Papazisis has been the recipient of several research, teaching, and mentoring awards from the Aristotle University of Thessaloniki, recognizing his contributions to medical education and translational research. His international reputation is reflected through invited participation in key regulatory and scientific committees, such as the UEMS and CIOMS. He has completed elite pharmacovigilance training at the WHO’s Uppsala Monitoring Centre and was honored as a pharmacovigilance representative in major EU pediatric and adult trials. Additionally, he is acknowledged for his leadership in the Vaccelerate project, which accelerates COVID-19 vaccine trials across Europe. His publication record, with over 110 articles and a citation count exceeding 3500, demonstrates his scholarly impact. His co-authorship of four book chapters in high-profile publications further reflects his academic excellence. These distinctions underscore his dedication to improving public health, ethical clinical research, and the safety of pharmaceuticals and vaccines worldwide.

Research Focus

Dr. Papazisis’s research focuses on clinical trials, pharmacovigilance, psychotropic and vaccine safety, pharmacoepidemiology, immunopharmacology, and neuropsychopharmacology. He specializes in evaluating the safety and efficacy of novel therapeutics in both adult and pediatric populations. His work integrates psychiatry and pharmacology, addressing critical challenges in drug monitoring, especially in real-world settings. He has contributed significantly to international research initiatives like c4c, JUSTSO, and Vaccelerate, where he led or supported multiple clinical trials in Greece. His interest in ethics is also evident in his leadership roles in medical ethics committees and involvement with CIOMS. His research approach combines regulatory science, clinical pharmacology, and public health. With a particular focus on patient safety and drug effectiveness, he advances evidence-based practices for improved therapeutic interventions. His collaborations with global institutions highlight a commitment to multidimensional, interdisciplinary research that bridges basic science, clinical medicine, and societal needs.

Conclusion

Professor Georgios Papazisis is highly deserving of the Best Researcher Award. His exceptional contributions to clinical pharmacology, ethical leadership, and global clinical trials reflect sustained excellence and international impact. His blend of academic productivity, regulatory leadership, and commitment to pharmacovigilance makes him a model candidate. By integrating digital innovation and expanding translational outreach, his already stellar profile could become even more transformative in the future.

 Publications

    • Title: Antipsychotic drugs: from receptor-binding profiles to metabolic side effects
      Authors: S. Siafis, D. Tzachanis, M. Samara, G. Papazisis
      Journal: Current Neuropharmacology, 2018
      Volume/Issue: 16(8), 1210–1223
      DOI: 10.2174/1570159X15666180509113904

    • Title: Eating habits, health attitudes and obesity indices among medical students in northern Greece
      Authors: M. Chourdakis, T. Tzellos, G. Papazisis, K. Toulis, D. Kouvelas
      Journal: Appetite, 2010
      Volume/Issue: 55(3), 722–725
      DOI: 10.1016/j.appet.2010.09.008

    • Title: Religious and spiritual beliefs, self‐esteem, anxiety, and depression among nursing students
      Authors: G. Papazisis, P. Nicolaou, E. Tsiga, T. Christoforou, D. Sapountzi‐Krepia
      Journal: Nursing & Health Sciences, 2014
      Volume/Issue: 16(2), 232–238
      DOI: 10.1111/nhs.12101

    • Title: Gabapentin and pregabalin in the treatment of fibromyalgia: a systematic review and a meta‐analysis
      Authors: T.G. Tzellos, K.A. Toulis, D.G. Goulis, G. Papazisis, V.A. Zampeli, A. Vakfari, …
      Journal: Journal of Clinical Pharmacy and Therapeutics, 2010
      Volume/Issue: 35(6), 639–656
      DOI: 10.1111/j.1365-2710.2009.01123.x

    • Title: Comorbidity of obsessive–compulsive disorder with obsessive–compulsive personality disorder: Does it imply a specific subtype of obsessive–compulsive disorder?
      Authors: G. Garyfallos, K. Katsigiannopoulos, A. Adamopoulou, G. Papazisis, …
      Journal: Psychiatry Research, 2010
      Volume/Issue: 177(1–2), 156–160
      DOI: 10.1016/j.psychres.2009.03.005

    • Title: Efficacy of pregabalin and gabapentin for neuropathic pain in spinal-cord injury: an evidence-based evaluation of the literature
      Authors: T.G. Tzellos, G. Papazisis, E. Amaniti, D. Kouvelas
      Journal: European Journal of Clinical Pharmacology, 2008
      Volume: 64, 851–858
      DOI: 10.1007/s00228-008-0515-1

    • Title: Psychological distress, anxiety and depression among nursing students in Greece
      Authors: G. Papazisis, E. Tsiga, N. Papanikolaou, I. Vlasiadis, D. Sapountzi-Krepia
      Journal: International Journal of Caring Sciences, 2008
      Volume/Issue: 1(1), 42
      Link: http://www.internationaljournalofcaringsciences.org/docs/vol1_issue1_07_papazisis.pdf

    • Title: Efficacy, safety and tolerability of green tea catechins in the treatment of external anogenital warts: a systematic review and meta‐analysis
      Authors: T.G. Tzellos, C. Sardeli, A. Lallas, G. Papazisis, M. Chourdakis, D. Kouvelas
      Journal: JEADV, 2011
      Volume/Issue: 25(3), 345–353
      DOI: 10.1111/j.1468-3083.2010.03733.x

    • Title: Epidemiology of antenatal depression among women with high-risk pregnancies due to obstetric complications: a scoping review
      Authors: I. Tsakiridis, V. Bousi, T. Dagklis, C. Sardeli, V. Nikolopoulou, G. Papazisis
      Journal: Archives of Gynecology and Obstetrics, 2019
      Volume: 300, 849–859
      DOI: 10.1007/s00404-019-05234-0

    • Title: Respiratory syncytial virus vaccines: a review of the candidates and the approved vaccines
      Authors: X. Topalidou, A.M. Kalergis, G. Papazisis
      Journal: Pathogens, 2023
      Volume/Issue: 12(10), 1259
      DOI: 10.3390/pathogens12101259

    • Title: Evaluation of dietary habits and assessment of cardiovascular disease risk factors among Greek university students
      Authors: M. Chourdakis, T. Tzellos, C. Pourzitaki, K.A. Toulis, G. Papazisis, …
      Journal: Appetite, 2011
      Volume/Issue: 57(2), 377–383
      DOI: 10.1016/j.appet.2011.06.005

    • Title: COVID-19 vaccines adverse events: potential molecular mechanisms
      Authors: M. Lamprinou, A. Sachinidis, E. Stamoula, T. Vavilis, G. Papazisis
      Journal: Immunologic Research, 2023
      Volume/Issue: 71(3), 356–372
      DOI: 10.1007/s12026-023-09313-6

    • Title: PDE5 inhibitors: in vitro and in vivo pharmacological profile
      Authors: D. Kouvelas, A. Goulas, G. Papazisis, C. Sardeli, C. Pourzitaki
      Journal: Current Pharmaceutical Design, 2009
      Volume/Issue: 15(30), 3464–3475
      DOI: 10.2174/138161209789271792

    • Title: Prevalence of antenatal depression and associated factors among pregnant women hospitalized in a high-risk pregnancy unit in Greece
      Authors: T. Dagklis, G. Papazisis, I. Tsakiridis, F. Chouliara, A. Mamopoulos, …
      Journal: Social Psychiatry and Psychiatric Epidemiology, 2016
      Volume: 51, 1025–1031
      DOI: 10.1007/s00127-016-1249-6

     

Timothea Toulopoulou | Cognitive Genetic | Best Researcher Award

Published on by Cognitive Scientist Awards

Prof. Dr. Timothea Toulopoulou | Cognitive Genetic | Best Researcher Award

Professor, Bilkent University

Prof. Dr. Timothea Toulopoulou is an internationally recognized neuropsychologist whose academic journey spans elite institutions across the UK, Asia, Europe, and the US. With a PhD in Neuropsychology from the University of London, her interdisciplinary expertise bridges neuroscience, psychology, psychiatry, and genetics. She is currently Professor at Bilkent University (Turkey) and Adjunct Professor at the Icahn School of Medicine at Mount Sinai (USA). Formerly at the University of Hong Kong and King’s College London, she has significantly contributed to the field of schizophrenia and psychosis through extensive twin and neuroimaging research. Her career reflects leadership, mentorship, and groundbreaking scholarship, with deep engagement in teaching, research supervision, and administrative leadership roles. Prof. Toulopoulou has played an integral part in curriculum development, academic advising, faculty recruitment, and ethical oversight. Her commitment to mental health research and education has left a lasting impact on global psychology and neuroscience communities.

Profile

Scholar

Scopus

📘 Education

Prof. Toulopoulou completed her academic training in the UK, earning her BA (Hons) in Social Sciences (Psychology) from the University of Sunderland in 1994. She then pursued a Master of Science in Neurosciences at the University of London in 1995. Driven by her deep interest in brain function and mental health, she obtained her PhD in Neuropsychology from the same institution in 2001. Her educational background laid a strong foundation for a career exploring the neurobiological basis of psychiatric disorders. Her studies provided a solid framework for combining clinical, genetic, and neuroimaging approaches in research. The integration of multidisciplinary methods from psychology, psychiatry, and neuroscience during her education fostered her later work on cognitive phenotypes and brain mechanisms related to psychosis, particularly in genetically at-risk populations. These early academic experiences established her as a leading expert in translational research bridging mind, brain, and behavior.

🏫 Experience 

Prof. Toulopoulou’s academic career began as a postdoctoral researcher at King’s College London, advancing to Lecturer and then tenured faculty. She served as Associate Professor at the University of Hong Kong and currently holds professorships at Bilkent University and adjunct roles at Mount Sinai and the University of Athens. Her academic appointments include Harvard Medical School, highlighting her global stature. She has taught a wide range of undergraduate and postgraduate courses, supervised over 20 PhD students and numerous MSc, MA, and undergraduate theses, and contributed to administrative leadership as Department Chair, curriculum coordinator, and PhD program director. She has been instrumental in faculty hiring, ethics review boards, and evaluation committees. Her roles span psychiatry, neuroscience, and psychology, blending clinical insight with research innovation. Her extensive international collaborations and interdisciplinary experience make her a uniquely positioned expert in cognitive neuroscience and psychosis research.

🏅 Awards and Honors

While specific named awards are not listed, Prof. Toulopoulou’s career is decorated with honors reflected through prestigious academic appointments and affiliations. Her tenure at globally respected institutions—including King’s College London, Harvard Medical School, and the University of Hong Kong—attests to her scholarly recognition. She has been invited to teach at top medical faculties and psychiatry departments, highlighting her expertise. Her selection to lead numerous faculty and ethics committees and her consistent role in curriculum development and PhD evaluation at Bilkent University demonstrate peer recognition of her leadership and academic excellence. Furthermore, she has served as a scientific referee and internal examiner at institutions such as the University of Hong Kong and King’s College London. Her postdoctoral mentorship and successful supervision of emerging scholars further underline her influential role in shaping the next generation of neuropsychologists and clinical researchers.

🔬 Research Focus 

Prof. Toulopoulou’s research focuses on understanding the neurocognitive and neurobiological underpinnings of psychosis and schizophrenia, with emphasis on gene-environment interactions. She employs twin studies, neuroimaging, cognitive assessments, and computational approaches to investigate psychosis proneness in healthy and clinical populations. Her work has explored the neural correlates of cannabis use, resilience and vulnerability in brain networks, and early biomarkers for schizophrenia. She has supervised numerous PhD and MSc projects addressing cortical maturation, working memory, language processing, and neurodevelopmental deviations. Her translational research connects clinical psychiatric phenomena with basic neuroscience, aiming to identify cognitive endophenotypes and brain signatures of genetic risk. She has published extensively on psychosis proneness and contributed to psychiatric genetics, cognitive neuroscience, and clinical psychology. Her interdisciplinary approach positions her as a thought leader in the quest to understand mental illness development, intervention, and prevention.

✅ Conclusion

Prof. Dr. Timothea Toulopoulou is highly suitable for the Best Researcher Award due to her robust academic pedigree, global institutional affiliations, deep mentoring impact, and research leadership in psychosis and neurodevelopment. Her work is methodologically rigorous and clinically significant, addressing core questions in psychiatric neuroscience. Minor improvements in public dissemination and interdisciplinary outreach could strengthen future candidacy even further. Overall, her profile embodies the hallmark of an award-winning researcher with international stature.

Publication

  • Title: Large recurrent microdeletions associated with schizophrenia
    Authors: H. Stefansson, D. Rujescu, S. Cichon, O.P.H. Pietiläinen, A. Ingason, …
    Year: 2008
    Citations: 3759

 

  • Title: Assessment of executive functions: Review of instruments and identification of critical issues
    Authors: R.C.K. Chan, D. Shum, T. Toulopoulou, E.Y.H. Chen
    Year: 2008
    Citations: 2365

 

  • Title: Genomic dissection of bipolar disorder and schizophrenia, including 28 subphenotypes
    Authors: D.M. Ruderfer, S. Ripke, A. McQuillin, J. Boocock, E.A. Stahl, J.M.W. Pavlides, …
    Year: 2018
    Citations: 727

 

  • Title: Disruption of the neurexin 1 gene is associated with schizophrenia
    Authors: D. Rujescu, A. Ingason, S. Cichon, O.P.H. Pietiläinen, M.R. Barnes, …
    Year: 2009
    Citations: 609

 

  • Title: Disease-associated epigenetic changes in monozygotic twins discordant for schizophrenia and bipolar disorder
    Authors: E.L. Dempster, R. Pidsley, L.C. Schalkwyk, S. Owens, A. Georgiades, F. Kane, …
    Year: 2011
    Citations: 553

 

  • Title: An integrated genetic-epigenetic analysis of schizophrenia: evidence for co-localization of genetic associations and differential DNA methylation
    Authors: E. Hannon, E. Dempster, J. Viana, J. Burrage, A.R. Smith, R. Macdonald, …
    Year: 2016
    Citations: 380

 

  • Title: Substantial genetic overlap between neurocognition and schizophrenia: genetic modeling in twin samples
    Authors: T. Toulopoulou, M. Picchioni, F. Rijsdijk, M. Hua-Hall, U. Ettinger, P. Sham, …
    Year: 2007
    Citations: 325

 

  • Title: Copy number variations of chromosome 16p13.1 region associated with schizophrenia
    Authors: A. Ingason, D. Rujescu, S. Cichon, E. Sigurdsson, T. Sigmundsson, …
    Year: 2011
    Citations: 301

 

  • Title: Association between BDNF val66 met genotype and episodic memory
    Authors: E. Dempster, T. Toulopoulou, C. McDonald, E. Bramon, M. Walshe, F. Filbey, …
    Year: 2005
    Citations: 241

 

  • Title: Pattern of neural responses to verbal fluency shows diagnostic specificity for schizophrenia and bipolar disorder
    Authors: S.G. Costafreda, C.H.Y. Fu, M. Picchioni, T. Toulopoulou, C. McDonald, …
    Year: 2011
    Citations: 229

Seong Son | Musculoskeletal | Best Researcher Award

Published on by Cognitive Scientist Awards

Prof. Dr. Seong Son | Musculoskeletal | Best Researcher Award

Professor, Gil Medical Center, Gachon university College of Medcine

Dr. Seong Son, M.D., Ph.D., is a distinguished neurosurgeon and Professor at the Department of Neurosurgery, Gil Medical Center, Gachon University College of Medicine in South Korea. Specializing in spine surgery, he has steadily advanced from internship to professorship, culminating in his current role as Director of the Spine Center. With over two decades of experience, Dr. Son’s clinical practice is supported by extensive academic involvement, numerous national and international affiliations, and a prolific publication record in minimally invasive spine techniques. His overseas training and visiting scholarship at UC Irvine further demonstrate his commitment to global medical excellence. A respected member of multiple neurosurgical and spinal societies, he contributes to the field through education, editorial duties, and cutting-edge research. His focus on minimally invasive spinal procedures continues to shape the field in South Korea and abroad.

Profile

Orcid

🔹 Education 

Dr. Son began his medical journey at Gachon Medical School (2000–2006), earning his bachelor’s degree in medicine. He continued at Gachon University’s Graduate School for his master’s degree (2009–2012), developing foundational expertise in neurosurgery. He then pursued a Ph.D. at Inha University College of Medicine (2015–2018), focusing on advanced neurosurgical techniques and spine pathologies. He obtained his Korean medical license in 2006 and became a board-certified neurosurgeon in 2011. His educational path reflects a consistent focus on excellence in clinical training and academic development, equipping him with deep scientific and practical knowledge in spine surgery. His studies laid the groundwork for an impactful career that bridges clinical practice, surgical innovation, and academic leadership in neurosurgical sciences.

🔹 Experience 

Dr. Seong Son has built a comprehensive clinical and academic career over nearly two decades. He started as an intern (2006–2007) and resident (2007–2011) in neurosurgery at Gil Medical Center, followed by a fellowship in the Spine Center (2011–2013). He served as Assistant Professor in trauma and spine neurosurgery (2013–2020), then advanced to Associate Professor (2020–2025), and became a full Professor in 2025. Since July 2024, he also serves as Director of the Spine Center. Internationally trained at institutions in the U.S., Germany, and Singapore, Dr. Son combines surgical practice with education, research, and leadership. His role has expanded from clinician to academic authority and institutional leader, shaping both patient outcomes and the future of neurosurgical training in South Korea.

🔹 Awards and Honors

While specific named awards are not listed, Dr. Seong Son’s honors are embedded in his progressive academic appointments, international fellowships, and scholarly roles. His overseas training, including the ASSET course at LAC+USC, a fellowship at Singapore’s National University Hospital, and a visiting scholarship at UC Irvine, highlight global recognition of his skills. His membership in premier societies like NASS and KOMISS, and his role on the editorial board of JMISST, further reflect his high professional standing. His contributions to leading textbooks and his appointment as Director of the Spine Center signify his excellence and leadership in spine surgery. These collective achievements serve as marks of peer respect, international collaboration, and recognition in academic neurosurgery.

🔹 Research Focus 

Dr. Son’s research centers on minimally invasive spine surgery, spinal trauma, degenerative disorders, and advanced surgical techniques for cervical and lumbar regions. His extensive contributions to surgical textbooks highlight his expertise in anterior cervical approaches, vertebroplasty, kyphoplasty, and geriatric spine care. As a member of multiple spinal societies, his work emphasizes clinical innovation, procedural safety, and functional outcomes in spine surgery. His studies contribute to optimizing patient recovery and reducing surgical invasiveness, enhancing long-term spine health. Dr. Son actively integrates evidence-based practice with cutting-edge research to shape the evolving standards of spinal neurosurgery in both Korean and international contexts.

✅ Conclusion

Dr. Seong Son stands out as a highly skilled clinician-researcher in spine surgery with a robust academic and clinical background. His expertise in minimally invasive techniques, leadership roles, and international exposure position him as a strong candidate for the Best Researcher Award. However, to fully align with global standards for research excellence, greater visibility through high-impact publications, grant leadership, and quantitative metrics would further strengthen his candidacy. Overall, he is a deserving nominee, particularly in clinically driven and translational research categories.

Publication

  • Title: Development of an Exercise Rehabilitation Functional Group for Individualized Exercise After Lumbar Spine Surgery
    Authors: Seong Son, Han Byeol Park, Chan Jong Yoo, Moon-Hee Kim, Byung Rhae Yoo, Jae Ang Sim
    Year: 2025
    Link: https://doi.org/10.3390/life15060943

 

  • Title: Comparison of the Efficacy of Zoledronate and Denosumab in Patients with Acute Osteoporotic Vertebral Compression Fractures: A Randomized Controlled Trial
    Authors: Seong Son, Michael Y. Oh, Byung-Rhae Yoo, Han-Byeol Park
    Year: 2024
    Link: https://doi.org/10.3390/jcm13072040

 

  • Title: Outcome of Percutaneous Endoscopic Lumbar Discectomy in Relation to the Surgeon’s Experience: Propensity Score Matching
    Authors: Seong Son, Michael Y. Oh, Han Byeol Park, Alexander M. Lopez
    Year: 2024
    Link: https://doi.org/10.3390/bioengineering11040312

 

  • Title: Digital therapeutics-based lumbar core exercise for patients with low back pain: A prospective exploratory pilot study
    Authors: Seong Son, Byung Rhae Yoo, Yu Mi Jeong
    Year: 2024
    Link: https://doi.org/10.1177/20552076231218154

 

  • Title: Low-Energy Transcranial Navigation-Guided Focused Ultrasound for Neuropathic Pain: An Exploratory Study
    Authors: Dong Hoon Shin, Seong Son, Eun Young Kim
    Year: 2023
    Link: https://doi.org/10.3390/brainsci13101433

 

  • Title: Efficacy of Transforaminal Endoscopic Lumbar Discectomy in Elderly Patients Over 65 Years of Age Compared to Young Adults
    Authors: Seong Son, Byung Rhae Yoo, Hee Jeong Kim, Sung Kyu Song, Yong Ahn
    Year: 2023
    Link: https://doi.org/10.14245/ns.2346192.096

 

 

  • Title: Reference Standard for Digital Infrared Thermography of the Surface Temperature of the Lower Limbs
    Authors: Ho Yeol Zhang, Seong Son, Byung Rhae Yoo, Tae-Mi Youk
    Year: 2023
    Link: https://doi.org/10.3390/bioengineering10030283

 

  • Title: Comparison of adjacent segment disease after minimally invasive versus open lumbar fusion: a minimum 10-year follow-up
    Authors: Jeong, Tae Seok; Son, Seong; Lee, Sang Gu; Ahn, Yong; Jung, Jong Myung; Yoo, Byung Rhae
    Year: 2022
    Link: https://doi.org/10.3171/2021.7.SPINE21408

 

  • Title: Comparison of Lateral Interbody Fusion and Posterior Interbody Fusion for Discogenic Low Back Pain
    Authors: Kim, Woo Kyung; Son, Seong; Lee, Sang Gu; Jung, Jong Myung; Yoo, Byung Rhae
    Year: 2022
    Link: https://doi.org/10.5137/1019-5149.JTN.35063-21.3

 

Lin Zhou | Cognitive Development | Best Researcher Award

Published on by Cognitive Scientist Awards

Assoc. Prof. Dr. Lin Zhou | Cognitive Development | Best Researcher Award

Dr. Zhou Lin is an accomplished Associate Professor at Shandong Sport University, serving as a master’s supervisor and Deputy Director of the Sports Rehabilitation Research Center. A recipient of the May 4th Outstanding Youth Medal from the Shanghai Health System and the Hebei Doctoral Innovation Program award, Dr. Zhou has made notable contributions to sports rehabilitation. With extensive clinical and academic experience, she focuses on musculoskeletal rehabilitation, cognitive function promotion through exercise, and digital health. She previously worked at Huadong Hospital, Fudan University, where she specialized in neurorehabilitation and orthopedic recovery. Dr. Zhou is actively engaged in scholarly activities, having published over 20 peer-reviewed articles in SCI/SSCI/CSCD journals, and serves as an editorial board member and reviewer for top international journals. Her current academic service includes membership in the Pediatric Rehabilitation Committee (DCD Group) of the Chinese Association of Rehabilitation Medicine.

Professional Profile

Education

Dr. Zhou Lin holds a strong academic foundation in medicine and rehabilitation sciences. She earned her Bachelor’s degree in Clinical Medicine, followed by a Master’s degree in Sports Rehabilitation, and subsequently completed her Doctorate in Sports Human Science. Her academic training spans clinical diagnostics, physical therapy, and the integration of kinesiology and cognitive health. The multi-disciplinary nature of her educational background equips her with a robust skill set for addressing complex health issues, particularly in musculoskeletal and neurological rehabilitation. Dr. Zhou’s academic journey reflects her deep commitment to both foundational medical science and applied rehabilitation practices. Her studies have enabled her to investigate the mechanisms of human movement and recovery while emphasizing evidence-based, life-cycle health interventions, making her an influential figure in China’s sports medicine and rehabilitation research landscape.

Experience

Dr. Zhou Lin began her clinical career in 2008 at Huadong Hospital affiliated with Fudan University, where she worked until 2016 in the Department of Rehabilitation. Her practice focused on orthopedic and neurorehabilitation, managing conditions like sports injuries, spinal pain syndromes, osteoarthritis, and post-surgical recovery. She is proficient in a range of physical therapy techniques, including Maitland and Mulligan joint mobilizations, PNF, Bobath, Brunnstrom, Rood therapies, McKenzie diagnostics, and kinesiology taping. After transitioning into academia, she became an Associate Professor at Shandong Sport University, where she also supervises graduate students and coordinates research at the Sports Rehabilitation Research Center. Additionally, she has served in national rehabilitation societies, including the DCD Group of the Pediatric Rehabilitation Committee and previously as a youth member of Shanghai Rehabilitation Medical Association committees. Her rich blend of clinical and academic roles uniquely positions her to train future practitioners while contributing to the development of rehabilitation science.

Research Interests

Dr. Zhou Lin’s research focuses on musculoskeletal rehabilitation, exercise-cognition interactions, and digital health promotion. Her work emphasizes improving physical function and cognitive well-being across the human lifespan through scientifically structured rehabilitation programs. She explores the interplay between physical activity and mental performance, especially in populations affected by neurological or orthopedic conditions. Additionally, her interest in digital health tools aligns with the growing need for tech-enabled, personalized rehabilitation strategies. Dr. Zhou has been involved in multiple high-impact research initiatives, including a project under the Hebei Doctoral Innovation Program, and has contributed to national and provincial research efforts like the National Social Science Foundation, Shandong Province Key R&D Plan, and Hebei Virtual Simulation Projects. Her role as an editor and reviewer for over ten international SCIE-indexed journals underlines her thought leadership and scientific influence in the global rehabilitation and public health communities.

Awards

Dr. Zhou Lin has been recognized for her excellence in healthcare and research with several prestigious awards. Notably, she received the May 4th Outstanding Youth Medal from the Shanghai Health System, an honor bestowed upon emerging leaders making impactful contributions in the medical field. She was also selected for the Hebei Province Doctoral Innovation Program, highlighting her innovative research contributions in sports rehabilitation. Her editorial roles in high-impact journals such as Journal of Medical Internet Research, BMC Public Health, Frontiers in Psychology, and Frontiers in Public Health demonstrate her recognition at the global level. Over the past three years, she has published 23 research articles in top-tier SCI, SSCI, and CSCD journals. These honors reflect her commitment to advancing rehabilitation science and promoting interdisciplinary innovations that improve patient care and health outcomes through evidence-based interventions and digital technologies.

Conclusion

Dr. Zhou Lin is a dynamic researcher, clinician, and educator whose interdisciplinary expertise in musculoskeletal rehabilitation, cognitive health, and digital innovation places her at the forefront of sports rehabilitation science in China and internationally.

 Publications

  • Understanding parental support for children’s 24‐hour movement behaviors based on an adapted HAPA framework: A three‐wave prospective study

    Applied Psychology: Health and Well-Being
    2025-06 | Journal article
    DOI: 10.1111/aphw.70034
    Part ofISSN: 1758-0846
    Part ofISSN: 1758-0854
    CONTRIBUTORS: Wei Liang; Guifang Liu; Ning Su; Ryan E. Rhodes; Yanping Duan; Chun-Qing Zhang; Lingfei Wang; Lin Zhou; Hanxiao Zhu

  • Associations of Reallocating Sedentary Time to Physical Activity and Sleep with Physical and Mental Health of Older Adults

    Medicine & Science in Sports & Exercise
    2024-10 | Journal article
    DOI: 10.1249/mss.0000000000003491
    Part ofISSN: 1530-0315
    Part ofISSN: 0195-9131
    CONTRIBUTORS: WEI LIANG; YANPING WANG; NING SU; HUIQI SONG; RYAN E. RHODES; XIANG WANG; BORUI SHANG; LIN ZHOU; QIAN HUANG; DANRAN BU et al.

  • Adherence to 24-Hour Movement Guidelines Among Chinese Older Adults: Prevalence, Correlates, and Associations With Physical and Mental Health Outcomes

    JMIR Public Health and Surveillance
    2024-06-13 | Journal article | Author
    DOI: 10.2196/46072
    Part ofISSN: 2369-2960
    CONTRIBUTORS: Wei Liang; Yanping Wang; Qian Huang; Borui Shang; Ning Su; Lin Zhou; Ryan E. Rhodes; 0000-0002-9093-7897; Yanping Duan

  • Electronic Health Literacy Scale-Web3.0 for Older Adults with Noncommunicable Diseases: Validation Study

    Journal of Medical Internet Research
    2024-06-03 | Journal article | Author
    DOI: 10.2196/52457
    Part ofISSN: 1438-8871
    CONTRIBUTORS: wenfei cai; Wei Liang; HUAXUAN LIU; Rundong Zhou; Given Names Deactivated Family Name Deactivated; Lin Zhou; Ning Su; Hanxiao Zhu; Yide Yang

  • Individual, family, and environmental correlates of fundamental motor skills among school-aged children: a cross-sectional study in China

    BMC Public Health
    2024-01-17 | Journal article
    DOI: 10.1186/s12889-024-17728-2
    Part of ISSN: 1471-2458
    CONTRIBUTORS: Yuxiu He; Lin Zhou; Wei Liang; Qi Liu; Wanxin Liu; Shijian Wang

Izabella Petre | Obstetrics and Gynecology | Women Researcher Award

Published on by Cognitive Scientist Awards

Dr. Izabella Petre | Obstetrics and Gynecology | Women Researcher Award

Dr. Petre (Șargan) Izabella is a distinguished Romanian medical professional specializing in obstetrics and gynecology. Based in Timișoara, she currently serves as the Head of the Obstetrics-Gynecology II Clinic at the County Emergency Clinical Hospital and as a University Lecturer at the “Victor Babeș” University of Medicine and Pharmacy. With over two decades of academic and clinical experience, she holds two doctoral degrees in medicine, complemented by master’s and postgraduate certifications in healthcare management, ultrasonography, and maternal-fetal medicine. Dr. Izabella’s career integrates medical education, clinical practice, and advanced research in women’s health, cardiovascular risks during pregnancy, and gynecological oncology. Her international recognition includes prestigious awards and membership in multiple medical societies. She is an influential mentor, author, and board member contributing to advancing reproductive health and evidence-based gynecological care in Romania and beyond.

Professional Profile

Scopus

Education

Dr. Izabella’s academic journey began with a degree in General Medicine (1997–2003) from “Victor Babeș” University, Timișoara. She pursued dual specialization: General Surgery (2004–2010) and Obstetrics-Gynecology (2011–2014), earning certifications through national examinations. She holds two doctoral degrees—one in Anatomy (2007), with research on gastric pathology, and another in Obstetrics-Gynecology (2019), focused on cardiovascular risk in pregnant women. Her formal education includes a Master’s in Healthcare and Social Services Management and advanced professional training in colposcopy, laparoscopy, maternal-fetal medicine, and ultrasonography. Additionally, she completed Level I and II psychopedagogical modules from West University of Timișoara to strengthen her academic teaching capacity. Dr. Izabella’s multidisciplinary expertise spans clinical, surgical, administrative, and pedagogical domains, making her a rare blend of physician-scientist-educator. She continuously updates her skills through postgraduate courses and certifications, including national accreditations in obstetric imaging and minimally invasive gynecological surgery.

Experience

Dr. Izabella boasts over 20 years of professional experience in medicine and academia. She currently holds the position of Head of Obstetrics-Gynecology Clinic II at the County Emergency Clinical Hospital in Timișoara (since 2019), where she also works as a senior consultant. Concurrently, she is Associate Professor at the “Victor Babeș” University of Medicine and Pharmacy, where she has served progressively as assistant professor (2004–2014), lecturer (2017–2018), and now conferențiar (since 2018). Her early career included residency in both General Surgery and Obstetrics-Gynecology. She has trained countless students and residents, integrating education with patient care and research. Her work emphasizes high-risk pregnancy management, cervical pathology, maternal-fetal health, and minimally invasive gynecological procedures. Beyond clinical duties, she coordinates academic curricula, research supervision, and medical education events. Her multilingual skills and experience in telemedicine further enhance her adaptability in global and digital healthcare environments.

Research Interests

Dr. Izabella’s research centers on maternal-fetal medicine, gynecological oncology, and cardiovascular risks in pregnancy, integrating clinical investigations with population-level health data. Her doctoral work examined the utility of arterial function assessment in pregnant women at cardiovascular risk. She has studied the pathophysiology of abnormal uterine bleeding, ultrasound scoring systems, subclinical atherosclerosis, and endometrial lesions in comorbid patients. Her projects under the Romanian research initiative PRECISI led to significant publications in indexed journals. Other topics of interest include analgesic use in early pregnancy, epidermolysis bullosa diagnosis, and employee satisfaction in healthcare systems. Dr. Izabella applies both clinical data analysis and experimental models, collaborating on cross-border studies and international programs. She also participates in medical education and knowledge dissemination through poster presentations, mentorship, and academic coordination. Her research goal is to optimize diagnostic accuracy, reduce maternal morbidity, and foster sustainable, patient-centered gynecological care, using both technological innovation and clinical insight.

Awards

Dr. Izabella has received numerous prestigious awards recognizing her contributions to gynecology, education, and cross-border healthcare collaboration. She won First Prize for Best Strategic Cross-Border Project (DKMT BABY RO HU, 2023), and Best Poster Awards at national and international congresses (e.g., SOGR 2024). She received the “Mircea Teodorescu”, “Ioan Lighezean”, and “Cornel Prostean” awards for clinical excellence and case presentations in obstetrics and gynecology. Her research has been supported under PRECISI programs, with notable publications in Diagnostics, Science of the Total Environment, and Sustainability. Additional recognitions include honorary diplomas, appreciation certificates from Romania’s top maternal-infant institutions, and awards for innovation in prenatal care. She has been acknowledged by societies such as the Romanian-German Society for Obstetrics-Gynecology. Her contributions have earned her reviewer roles in ISI journals and invitations to international scientific boards, reflecting her dedication to excellence and her impact in reproductive health sciences.

Conclusion

Dr. Izabella Petre is an accomplished physician-scientist and academic whose exceptional contributions to obstetrics-gynecology, maternal-fetal medicine, and women’s healthcare leadership are underscored by her dual doctorates, high-impact research, prestigious awards, and dedication to clinical excellence and medical education at national and international levels.

 Publications

Nastaran Zamani | Exercise – Appetite – Obesity | Best Researcher Award

Published on by Cognitive Scientist Awards

Assist. Prof. Dr. Nastaran Zamani | Exercise – Appetite – Obesity | Best Researcher Award

Dr. Nastaran Zamani is a distinguished Iranian neuroscientist and Assistant Professor in the Department of Biology at Payame Noor University, Tehran. With a research career grounded in neurophysiology and Alzheimer’s disease models, she has made valuable contributions to understanding the effects of neuroprotective agents like memantine, vitamin D, folic acid, and DHA on cognitive function. Her expertise spans from electrophysiological recordings of hippocampal neurons to behavioral studies in rodent models. Dr. Zamani has actively collaborated with renowned researchers and co-authored over 20 peer-reviewed articles published in leading journals in neuroscience, physiology, and pharmacology. Her work bridges cellular neurobiology and therapeutic research, reflecting an interdisciplinary approach. Dr. Zamani is also known for her participation in national and international scientific congresses. Through her teaching and mentoring roles, she fosters academic growth and promotes scientific inquiry among students and young researchers in Iran. Her commitment to neuroscience research and education continues to inspire many in the field.

Professional Profile

Googlescholar

Education

Dr. Nastaran Zamani earned her Ph.D. in Animal Physiology from Shahid Chamran University of Ahvaz in 2019, with a doctoral thesis focused on the electrophysiological and behavioral effects of memantine and DHA on hippocampal CA1 neurons and spatial memory in Alzheimer’s disease rat models, under the supervision of Prof. Ahmad Ali Moazedi. She completed her MSc in Animal Physiology from Razi University, Kermanshah, in 2004, where her thesis explored the hematological effects of sodium nitrate in mice, co-supervised by Dr. Syrus Shamili and Dr. Syrus Ghobadi. Her academic foundation was built at the University of Isfahan, where she received her BSc in Biology with a focus on Animal Sciences in 1999. Her education reflects a consistent and deep interest in the physiological and biochemical mechanisms underlying cognitive and neurodegenerative disorders, forming the basis of her current research in neuroscience and therapeutic interventions for Alzheimer’s disease and related neurological conditions.

Experience

Dr. Zamani began her academic career as a faculty instructor in the Department of Biology at Payame Noor University from 2011 to 2019. Since 2019, she has held the position of Assistant Professor in the same department. She has over a decade of teaching experience, mentoring undergraduate and graduate students in physiology, neurobiology, and experimental research techniques. Her research focuses on Alzheimer’s disease models, involving electrophysiology, behavioral neuroscience, and pharmacological interventions. Dr. Zamani has presented her findings in more than ten national and international conferences and has authored over 20 peer-reviewed journal articles in neuroscience and physiology. In addition to teaching and research, she has participated in various academic development workshops on molecular biology, drug delivery, data analysis using MATLAB, and scientific writing. Her continuous contributions to neuroscience research and education have strengthened her role as a dedicated academic professional in the Iranian scientific community.

Research Interests

Dr. Zamani’s research centers on the neurophysiological and therapeutic mechanisms underlying Alzheimer’s disease, with a primary focus on hippocampal CA1 neuron activity, memory, and learning. She explores the pharmacological effects of memantine, folic acid, vitamin B12, DHA, and vitamin D in rodent models of neurodegeneration, using electrophysiological recordings and behavioral assessments such as maze tests. Her investigations examine how these compounds influence spatial learning, memory deficits, neuroinflammation, and oxidative stress in Alzheimer’s models. She has expanded her research to include studies on motor coordination, depression, anxiety, and thermal dysregulation related to neurological disorders, as well as broader physiological effects of exercise and natural antioxidants. Her interdisciplinary approach integrates neuroscience, pharmacology, and physiology, supported by collaborations with international researchers and active engagement in congresses and workshops. By bridging cellular mechanisms and therapeutic strategies, Dr. Zamani’s work contributes significantly to preclinical efforts targeting Alzheimer’s disease and cognitive disorders.

Awards

While formal award titles are not explicitly listed, Dr. Nastaran Zamani’s consistent scholarly productivity and academic recognition are evident through her extensive peer-reviewed publications, conference participations, and workshop invitations. She has been selected to present at prestigious neuroscience congresses, such as the Congress of Basic and Clinical Neuroscience, and has contributed to multiple multidisciplinary international collaborations, demonstrating her recognition within the academic community. Her research contributions to Alzheimer’s disease models have earned her collaborative roles in high-impact studies published in journals like Frontiers in Physiology, Molecular and Cellular Biochemistry, and Cytotherapy. She has also participated in professional development programs hosted by Tehran University of Medical Sciences, Elsevier Research Academy, and the International Brain Research Organization, further reflecting her ongoing commitment to academic excellence. Dr. Zamani’s profile highlights the high regard she holds among peers and institutions for her active role in advancing neurophysiological research in Iran and beyond.

Conclusion:

Dr. Nastaran Zamani is a dedicated neuroscientist whose innovative research on neurodegeneration and therapeutic interventions for Alzheimer’s disease has significantly advanced our understanding of cognitive function, making her a valuable contributor to the global neuroscience community.

 

Top Noted Publications

Andrey Popatanasov | Neuroscience | Best Researcher Award

Published on by Cognitive Scientist Awards

Dr. Andrey Popatanasov | Neuroscience | Best Researcher Award 

Research Assistant, at Institute of Neurobiology, Bulgarian Academy of Sciences, Bulgaria.

Andrey Popatanasov is a dedicated Research Assistant at the Institute of Neurobiology, Bulgarian Academy of Sciences (BAS). His academic journey is distinguished by a multidisciplinary approach: he holds Bachelor’s degrees in Psychology, Physics, and Biology, complemented by Master’s degrees in Clinical Psychology, Medical Physics, and Molecular Biology. Currently, he is pursuing a PhD in Human and Animal Physiology, expected to be conferred this year. Professionally, Popatanasov has been affiliated with various institutes under BAS, contributing to integrative research that bridges the gap between basic science and its application to human well-being. His work aims to advance our understanding of neurobiological mechanisms and their implications for human health.

Professional Profile

Scopus

ORCID

Education

Popatanasov’s educational foundation is both broad and deep, reflecting his commitment to understanding complex biological systems. He earned Bachelor’s degrees in Psychology, Physics, and Biology, providing him with a diverse scientific perspective. Building on this, he completed Master’s degrees in Clinical Psychology, Medical Physics, and Molecular Biology, each aligning with his evolving research interests. Currently, he is finalizing his PhD in Human and Animal Physiology, which will further enhance his expertise in neurobiology. This extensive academic background equips him to approach research questions from multiple disciplinary angles, fostering innovative solutions to complex problems in neuroscience and related fields.

Experience

Throughout his academic and professional career, Popatanasov has gained substantial experience in research and academia. He has been involved in various research projects at institutes of the Bulgarian Academy of Sciences, where he applied his multidisciplinary training to investigate neurobiological phenomena. Currently, as a Research Assistant at the Institute of Neurobiology, he contributes to studies that explore the molecular and physiological aspects of the nervous system. His role encompasses experimental design, data analysis, and dissemination of findings, all aimed at advancing scientific knowledge and its practical applications in medicine and healthcare.

Research Interests

Popatanasov’s research interests lie at the intersection of neuroscience, psychology, biology, and physics. He investigates the molecular mechanisms underlying cognitive, affective, and pro-social behaviors, particularly in pathological conditions. His work includes in silico and in vitro studies on ligand interactions with brain biomolecules, as well as the impact of electromagnetic radiation from quantum generators on living and non-living matter. Additionally, he explores the relationship between language complexity and brain development in children with disabilities. These interdisciplinary pursuits aim to uncover fundamental insights into brain function and inform therapeutic strategies for various neurological disorders.

Awards

While specific awards are not detailed in the provided information, Popatanasov’s contributions to neuroscience and interdisciplinary research are noteworthy. His work has been recognized through his involvement in peer-reviewed publications and editorial roles, indicating a respected standing within the scientific community. His dedication to advancing knowledge in neurobiology and related fields reflects a commitment to excellence in research and its application to human health.

Top Noted Publications

Popatanasov has co-authored several significant publications in reputable scientific journals. One notable article is “New Insights into the Cytoarchitecture of the Rat Spinal Trigeminal Nucleus,” published in the Proceedings of the Bulgarian Academy of Sciences in July 2024. This study provides detailed histological analysis of the spinal trigeminal nucleus, contributing to the understanding of sensory processing in the trigeminal system. Another key publication is “Expression of Neurotrophic Factors and Their Receptors in the Rat Spinal Trigeminal Nucleus,” also in the Proceedings of the Bulgarian Academy of Sciences, published in September 2024. This research examines the role of neurotrophic factors in neuronal differentiation and survival, with implications for pain modulation and neuroplasticity. These publications underscore Popatanasov’s active engagement in advancing neurobiological research.proceedings.bas.bg+2proceedings.bas.bg+2proceedings.bas.bg+2proceedings.bas.bg

Publications with Hyperlinks and Citation Information

🧠 1. New Insights into the Cytoarchitecture of the Rat Spinal Trigeminal Nucleus

DOI: 10.7546/CRABS.2024.07.11

This study delves into the structural organization of the spinal trigeminal nucleus (SpV), a pivotal relay station for processing sensory information from the face, head, and oral cavity. Historically considered a continuous structure, it was revealed to be subdivided into three distinct subnuclei: oral, interpolar, and caudal. Utilizing histological techniques, the researchers identified unique cytoarchitectural features characteristic of each subnucleus, providing insights into the spatial distribution and density of neuronal populations across the rostrocaudal extent of the SpV. These findings enhance the understanding of the neural circuitry underlying sensory processing in the trigeminal system and may have implications for the diagnosis and treatment of disorders involving altered trigeminal function. proceedings.bas.bg+1proceedings.bas.bg+1

🧬 2. Expression of Neurotrophic Factors and Their Receptors in the Rat Spinal Trigeminal Nucleus

DOI: 10.7546/CRABS.2024.09.15

In this follow-up study, the authors investigated the expression of neurotrophic factors—nerve growth factor (NGF), brain-derived neurotrophic factor (BDNF), neurotrophin-3 (NT-3), and glial-derived neurotrophic factor (GDNF)—and their corresponding receptors in the rat SpV. Using primary antibodies against these neurotrophic factors and their receptors, the researchers found immunoreactive cells scattered along the entire length of the nucleus in all three subnuclei. Notably, the majority of spinal trigeminal neurons were intensely immunostained for all the neurotrophic factors examined and were richly endowed with their Trk receptors. The study also observed regional variations in the expression levels of these factors and receptors within the subnuclei. Given that these neurotrophic factors are involved in mechanisms of central sensitization in trigeminal nociceptive pathways, the findings suggest that neurotrophins may contribute to a better understanding of the fundamental mechanisms of orofacial pain. proceedings.bas.bg

Conclusion

Andrey Popatanasov is a highly interdisciplinary researcher with a solid academic and professional foundation. His efforts to integrate diverse scientific domains (psychology, neuroscience, physics, biology) are commendable. He has made meaningful contributions to both theoretical and applied research, especially in brain science, cognitive behavior, and molecular biology.